Affiliation:
1. Molecular Medicine and Therapeutics Laboratory, CPMB Osmania University Hyderabad India
2. Thoracic Oncology, Inova Schar Cancer Institute Fairfax Virginia USA
3. Applied Computational Intelligence Lab Missouri University of Science and Technology Rolla Missouri USA
Abstract
AbstractBackgroundMutations in kinases are the most frequent genetic alterations in cancer; however, experimental evidence establishing their cancerous nature is available only for a small fraction of these mutants.AimsPredicition analysis of kinome mutations is the primary aim of this study. Further objective is to compare the performance of various softwares in pathogenicity prediction of kinase mutations.Materials and methodsWe employed a set of computational tools to predict the pathogenicity of over forty‐two thousand mutations and deposited the kinase‐wise data in Mendeley database (Estimated Pathogenicity of Kinase Mutants [EPKiMu]).ResultsMutations are more likely to be drivers when being present in the kinase domain (vs. non‐kinase domain) and belonging to hotspot residues (vs. non‐hotspot residues). We identified that, while predictive tools have low specificity in general, PolyPhen‐2 had the best accuracy. Further efforts to combine all four tools by consensus, voting, or other simple methods did not significantly improve accuracy.DiscussionThe study provides a large dataset of kinase mutations along with their predicted pathogenicity that can be used as a training set for future studies. Furthermore, a comparative sensitivity and selectivity of commonly used computational tools is presented.ConclusionPrimary‐structure‐based in silico tools identified more cancerous/deleterious mutations in the kinase domains and at the hot spot residues while having higher sensitivity than specificity in detecting deleterious mutations.
Funder
Indian Council of Medical Research
Subject
Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology